ENDRA Life Sciences Statistics

Total Valuation

NDRA has a market cap or net worth of $2.20 million. The enterprise value is -$2.10 million.

Market Cap	2.20M
Enterprise Value	-2.10M

Important Dates

The last earnings date was Monday, March 31, 2025, before market open.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

NDRA has 536,908 shares outstanding.

Current Share Class	536,908
Shares Outstanding	536,908
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1,483.17%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	0.16%
Float	536,821

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.33
P/TBV Ratio	0.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.07.

Current Ratio	6.10
Quick Ratio	5.83
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -149.45% and return on invested capital (ROIC) is -77.34%.

Return on Equity (ROE)	-149.45%
Return on Assets (ROA)	-62.40%
Return on Invested Capital (ROIC)	-77.34%
Return on Capital Employed (ROCE)	-105.46%
Revenue Per Employee	n/a
Profits Per Employee	-$419,928
Employee Count	21
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.60% in the last 52 weeks. The beta is 0.19, so NDRA's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-99.60%
50-Day Moving Average	4.59
200-Day Moving Average	40.11
Relative Strength Index (RSI)	46.69
Average Volume (20 Days)	8,752

Short Selling Information

The latest short interest is 40,610, so 7.56% of the outstanding shares have been sold short.

Short Interest	40,610
Short Previous Month	28,334
Short % of Shares Out	7.56%
Short % of Float	7.56%
Short Ratio (days to cover)	3.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.98M
Pretax Income	-9.89M
Net Income	-8.82M
EBITDA	-7.92M
EBIT	-7.98M
Earnings Per Share (EPS)	-$128.89

Full Income Statement

Balance Sheet

The company has $4.75 million in cash and $445,346 in debt, giving a net cash position of $4.30 million or $8.01 per share.

Cash & Cash Equivalents	4.75M
Total Debt	445,346
Net Cash	4.30M
Net Cash Per Share	$8.01
Equity (Book Value)	6.60M
Book Value Per Share	12.35
Working Capital	4.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.06 million and capital expenditures -$22,884, giving a free cash flow of -$8.08 million.

Operating Cash Flow	-8.06M
Capital Expenditures	-22,884
Free Cash Flow	-8.08M
FCF Per Share	-$15.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NDRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-400.60%
FCF Yield	-367.16%

Analyst Forecast

The average price target for NDRA is $14,000.00, which is 341,363.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14,000.00
Price Target Difference	341,363.42%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 7, 2024. It was a reverse split with a ratio of 0.0285714:1.

Last Split Date	Nov 7, 2024
Split Type	Reverse
Split Ratio	0.0285714:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2